Repurposing of Thalidomide As a Potential Therapeutic Agent for Idiopathic Pulmonary Fibrosis: An In Silico Molecular Docking Study. Int. J. Res. Pharm. Sci. Technol. 2026, 9 (3). https://doi.org/10.33974/st7x9s50.